Design, analysis and reporting of multi-arm trials and strategies to address multiple testing

Abstract

Strategies to reduce type I and type II errors are inconsistently employed in multi-arm trials. Important analytical differences exist between planned analyses in clinical-trial protocols and subsequent publications, which may suggest selective reporting of analyses.